Table 3 |
||
|
Independent predictors of mortality in CTD-PAH, determined using multivariable proportional hazards regression analysis |
||
|
Variable |
Adjusted HR (95% CI) |
P |
|
|
||
|
WHO FC at baseline |
3.42 (1.25 to 9.36) |
0.04 |
|
mRAP at baseline, mmHg |
1.13 (1.04 to 1.24) |
0.007 |
|
Baseline 6MWD*, m |
0.64 (0.43 to 0.97) |
0.04 |
|
Pericardial effusion |
3.39 (1.07 to 10.68) |
0.04 |
|
Warfarin therapy |
0.20 (0.05 to 0.78) |
0.02 |
|
Combination therapy |
0.20 (0.05 to 0.83) |
0.03 |
|
|
||
|
*hazard ratio relates to each 100 metres increase in 6MWD 6MWD, six minute walk distance; 95% CI, 95% confidence interval; HR, hazard ratio; mRAP, mean right atrial pressure; WHO FC, World Health Organization functional class |
||
|
Ngian et al. Arthritis Research & Therapy 2012 14:R213 doi:10.1186/ar4051 |
||
